my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
COTI is formed around a unique computational platform technology called CHEMSAS®, which allows for the accelerated identification, profiling and optimization of targeted small molecules potentially effective in the treatment of human diseases for which current therapy is either lacking or ineffectiv more
Critical Outcome Technologies Inc. (COTI) announced that a composition of matter patent has been granted by the United States Patent and Trademark Office (USPTO) on October 11, 2011, representing a major milestone for the Company and its most advanced oncology drug candidate, COTI-2.“The granting of more
Critical Outcome Technologies Inc. (COTI) announced the results of recent experiments demonstrating clear evidence of COTI-2's ability to significantly inhibit the growth of cancer cells that over express Akt/Akt2, confirming it as a promising targeted therapy candidate. COTI-2 is the first drug dev more
Critical Outcome Technologies Inc. (COTI) announced positive results from the first phase of its HIV integrase inhibitor discovery program. These results provide novel intellectual property to the Company and further validation of the CHEMSAS® drug discovery technology. The significance of these r more
Immune Network, Ltd. (formerly Immune Network Research Ltd.) is a biotechnology company. It is engaged in the development of immunological products for the diagnosis, prevention and treatment of disorders of the immune system. INR develops immunological products for the treatment of diseases related more
Critical Outcome Technologies Inc. (COTI) is a publicly held biotechnology company. It is engaged in the discovery and pre-clinical development of small molecules for the treatment of various human diseases. The company has developed its proprietary platform technology chemsas based on combination o more
Global Health Ventures Inc. (Global Health) is a publicly held healthcare technology financial company. It is principally engaged in the development of platform technologies for drug delivery through the sublingual (under the tongue) route. This method reduces side effects with lower dosage than con more
Learn how Aureus Pharma streamlines critical research functions… EVENT SCHEDULE ISSX Meeting September 4-8, 2010 XXIst ISMC September 5-9, 2010 Drug Drug Interactions Webinar September 21, 2010 See all events REQUEST WEB DEMO Examine Aureus Pharma’s Knowledge Management System from your more
LIMS RESOURCE CENTER HORIZON® LIMS CAREERS AT CHEMWARE PRESS ROOM ABOUT US visitor and customer portal Set up your free mychemware.com account in 5 minutes: Tell us something about your laboratory and LIMS interests, and we personalize the site for you. LOG IN NOW... NEWS EVENTS VISITORS Top News St more
Welcome to BAC BAC is an established biotech company providing the life science industry with unparalleled protein purification technologies for drug manufacture and research. These CaptureSelect ® products possess a combination of unique properties such as stability, affinity and selectivity, which more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
